Susan Wong

2.2k citations

39 papers · 833 indexed · h-index 17

Pharmacology top 1%
Oncology top 10%
Molecular Biology
Nutrition and Dietetics top 10%
Pediatrics, Perinatology and Child Health top 10%

Co-authors: Kerin O’Dea Jason Halladay Jane R. Kenny Vincent J. Wacher S. Cyrus Khojasteh Lisa M. Almond I. Gardner Masoud Jamei
Topics: Pharmacogenetics and Drug Metabolism (19 papers)Drug Transport and Resistance Mechanisms (12 papers)Pharmacological Effects and Toxicity Studies (6 papers)
Cited by: Pharmacology Oncology Transplantation
Journals: Analytical Chemistry American Journal of Clinical Nutrition Journal of Pharmacology and Experimental Therapeutics
Partner nations: United States France United Kingdom

In The Last Decade

Susan Wong

38 papers receiving 761 citations

Peers

Countries citing papers authored by Susan Wong

Since Specialization

Citations

This map shows the geographic impact of Susan Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Wong more than expected).

Fields of papers citing papers by Susan Wong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Wong. The network helps show where Susan Wong may publish in the future.

Co-authorship network of co-authors of Susan Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Wong. A scholar is included among the top collaborators of Susan Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Wong. Susan Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	GTP1 metabolic stability assessment: A study of the tau PET tracer [18F]GTP1 2023 ·Nuclear Medicine and Biology ·Jan Mařı́k,(unknown),Gauri Deshmukh,Donglu Zhang,Jeff N. Tinianow,Jingwei Cai,Susan Wong,Sudheer Bobba,Kevin DeMent,Ning Liu,Jason Halladay,Sandra Sanabria Bohórquez,Lionel Cheruzel,S. Cyrus Khojasteh	1
2	An Integrated Strategy for Assessing the Metabolic Stability and Biotransformation of Macrocyclic Peptides in Drug Discovery toward Oral Delivery 2022 ·Analytical Chemistry ·(unknown),Shaofei Ji,Wei Wang,Susan Wong,Chun‐Wan Yen,(unknown),Dennis Leung,Emile G. Plise,Shu Zhang,Chenghong Zhang,(unknown),Donglu Zhang,Christian N. Cunningham,S. Cyrus Khojasteh,Dian Su	13
3	Investigating the Utility of Humanized Pregnane X Receptor-Constitutive Androstane Receptor-CYP3A4/7 Mouse Model to Assess CYP3A-Mediated Induction 2021 ·Drug Metabolism and Disposition ·Justin Q. Ly,Susan Wong,Liling Liu,Ruina Li,(unknown),Jae H. Chang	3
4	Does In Vitro Cytochrome P450 Downregulation Translate to In Vivo Drug‐Drug Interactions? Preclinical and Clinical Studies With 13‐cis‐Retinoic Acid 2019 ·Clinical and Translational Science ·Faith Stevison,(unknown),Jane R. Kenny,Susan Wong,Cathryn A. Hogarth,John K. Amory,Nina Isoherranen	22
5	Applying Stable Isotope Labeled Amino Acids in Micropatterned Hepatocyte Coculture to Directly Determine the Degradation Rate Constant for CYP3A4 2017 ·Drug Metabolism and Disposition ·Ryan Takahashi,Sheerin Shahidi-Latham,Susan Wong,Jae H. Chang	13
6	Strategy for CYP3A Induction Risk Assessment from Preclinical Signal to Human: a Case Example of a Late-Stage Discovery Compound 2017 ·Pharmaceutical Research ·Jialin Mao,Peter W. Fan,Susan Wong,(unknown),(unknown),Brian Dean,Cornelis E. C. A. Hop,Matthew Wright,Yuan Chen	3
7	Characterizing thein vitrospecies differences in N-glucuronidation of a potent pan-PIM inhibitor GNE-924 containing a 3,5-substituted 6-azaindazole 2017 ·Xenobiotica ·Molly Lin,Justin Q. Ly,Ryan Takahashi,John Chen,Alan Deese,(unknown),Aleksandr Kolesnikov,Susan Wong,Xiaojing Wang,Jae H. Chang	0
8	Prediction of Drug-Drug Interactions Arising from CYP3A induction Using a Physiologically Based Dynamic Model 2016 ·Drug Metabolism and Disposition ·Lisa M. Almond,Sophie Mukadam,I. Gardner,(unknown),Susan Wong,Oliver Hatley,Sun Tee Tay,K Rowland‐Yeo,Masoud Jamei,Amin Rostami‐Hodjegan,Jane R. Kenny	91
9	A Physiologically Based Pharmacokinetic Modeling Approach to Predict Disease–Drug Interactions: Suppression of CYP3A by IL-6 2013 ·Clinical Pharmacology & Therapeutics ·(unknown),Lisa M. Almond,Amin Rostami‐Hodjegan,I. Gardner,Masoud Jamei,Suzanne Tay,Susan Wong,Amita Joshi,Jane R. Kenny	86
10	Comparison of In Vitro-In Vivo Extrapolation of Biliary Clearance Using an Empirical Scaling Factor Versus Transport-Based Scaling Factors in Sandwich-Cultured Rat Hepatocytes 2013 ·Journal of Pharmaceutical Sciences ·Peng Zou,Xingrong Liu,Susan Wong,Meihua Rose Feng,Bianca M. Liederer	16
11	An ‘all-inclusive’ 96-well cytochrome P450 induction method: Measuring enzyme activity, mRNA levels, protein levels, and cytotoxicity from one well using cryopreserved human hepatocytes 2012 ·Journal of Pharmacological and Toxicological Methods ·Jason Halladay,Susan Wong,S. Cyrus Khojasteh,Susan Grepper	27
12	Preclinical Assessment of the Absorption and Disposition of the Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor GDC-0980 and Prediction of Its Pharmacokinetics and Efficacy in Human 2012 ·Drug Metabolism and Disposition ·Laurent Salphati,Jodie Pang,Emile G. Plise,Leslie B. Lee,Alan G. Olivero,Wei Wei Prior,Deepak Sampath,Susan Wong,Xiaolin Zhang	30
13	Preclinical pharmacokinetics of the novel PI3K inhibitor GDC-0941 and prediction of its pharmacokinetics and efficacy in human 2011 ·Xenobiotica ·Laurent Salphati,Jodie Pang,Emile G. Plise,(unknown),Jason Halladay,Alan G. Olivero,Patrick J. Rudewicz,Qingping Tian,Susan Wong,Xiaolin Zhang	20
14	Preclinical assessment of the absorption, distribution, metabolism and excretion of GDC-0449 (2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methylsulfonyl)benzamide), an orally bioavailable systemic Hedgehog signalling pathway inhibitor 2009 ·Xenobiotica ·Harvey Wong,(unknown),(unknown),Jason Halladay,Jane R. Kenny,Hanson La,James C. Marsters,Emile G. Plise,Patrick J. Rudewicz,Kirk Robarge,Young G. Shin,Susan Wong,(unknown),S. Cyrus Khojasteh	47
15	Metabolic Stability Screen for Drug Discovery Using Cassette Analysis and Column Switching 2007 ·Drug Metabolism Letters ·Jason Halladay,Susan Wong,(unknown),(unknown),S. Cyrus Khojasteh-Bakht	20
16	Peppermint Oil Enhances Cyclosporine Oral Bioavailability in Rats: Comparison with d‐α‐Tocopheryl Poly(ethylene glycol 1000) Succinate (TPGS) and Ketoconazole 2002 ·Journal of Pharmaceutical Sciences ·Vincent J. Wacher,Susan Wong,(unknown)	41
17	Sirolimus Oral Absorption in Rats Is Increased by Ketoconazole but Is Not Affected by d-α-Tocopheryl Poly(Ethylene Glycol 1000) Succinate 2002 ·Journal of Pharmacology and Experimental Therapeutics ·Vincent J. Wacher,Jeffrey A. Silverman,Susan Wong,(unknown),(unknown),(unknown),Xiang‐Qing Yu,Daniel J. O’Mahony,Zebunnissa Ramtoola	16
18	Minimal effect of ketoconazole on cyclosporine (SangCyA^TM) oral absorption and first‐pass metabolism in rats: evidence of a significant vehicle effect on SangCyA absorption 2002 ·Biopharmaceutics & Drug Disposition ·Susan Wong,(unknown),Vincent J. Wacher	5
19	Factors affecting the rate of hydrolysis of starch in legumes 1985 ·American Journal of Clinical Nutrition ·Susan Wong,Kathy Traianedes,Kerin O’Dea	36
20	The rate of starch hydrolysis in vitro does not predict the metabolic responses to legumes in vivo 1983 ·American Journal of Clinical Nutrition ·Kerin O’Dea,Susan Wong	25

About Susan Wong

Susan Wong is a scholar working on Pharmacology, Pharmaceutical Science and Oncology, having authored 39 papers that have together received 833 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (19 papers), Drug Transport and Resistance Mechanisms (12 papers) and Pharmacological Effects and Toxicity Studies (6 papers). The work is most often cited by research in Pharmacology (314 citations), Oncology (248 citations) and Transplantation (18 citations). Susan Wong has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Kerin O’Dea, Jason Halladay, Jane R. Kenny, Vincent J. Wacher, S. Cyrus Khojasteh, Lisa M. Almond, I. Gardner, Masoud Jamei, Amin Rostami‐Hodjegan and Emile G. Plise. Their work appears in journals such as Analytical Chemistry, American Journal of Clinical Nutrition and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact